Schwerzenbach, Switzerland
obvioTec AG is a Switzerland based startup that is dedicated to revolutionizing quality control in the pharmaceutical and life science industries. The company's slogan "We develop breakthrough AI-supported technology for the non-destructive inspection of pharmaceutical products" signifies its focus on cutting-edge innovation.
obvioTec's non-destructive quality inspection solutions, which utilize Terahertz and Gigahertz technology in combination with AI, present a compelling alternative to current visual inspection methodologies for both drug containment solutions and packaged pharmaceuticals. The company positions itself as the premier partner for developing new inspection solutions, offering comprehensive support from feasibility studies to prototyping and customization.
One of obvioTec's strengths lies in its collaborations with industry-leading technology firms, ensuring cutting-edge solutions tailored to specific needs. The company's clients include global leading life science companies and their suppliers, demonstrating its credibility and market reach within the Health Care and Manufacturing industries.
Since its inception in 2018, obvioTec has laid a strong foundation in the market, but as of now, no specific information regarding the last investment and investors is available. However, with its innovative approach and potential to disrupt the industry, obvioTec presents an intriguing opportunity for venture capital firms seeking investment targets in the health and manufacturing sectors.
